• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Early benefit of implantable cardioverter defibrillator therapy in patients waiting for cardiac transplantation.

作者信息

Lorga-Filho A, Geelen P, Vanderheyden M, Malacky T, Primo J, Goethals M, Wellens F, Brugada P

机构信息

Cardiovascular Center, OLV-Hospital, Aalst, Belgium.

出版信息

Pacing Clin Electrophysiol. 1998 Sep;21(9):1747-50. doi: 10.1111/j.1540-8159.1998.tb00274.x.

DOI:10.1111/j.1540-8159.1998.tb00274.x
PMID:9744438
Abstract

The ICD can effectively recognize and treat ventricular arrhythmias that can lead to sudden death. Sudden death is a major problem in patients awaiting heart transplantation. We reviewed our experience with the ICD in patients with malignant ventricular arrhythmias waiting for cardiac transplantation. Nineteen patients were included. Seventeen were men, mean age was 54 +/- 11 years (range 17-66) and the left ventricular ejection fraction was 22% +/- 10% (range 9%-46%). After a mean follow-up of 6 +/- 5 months (range 1-20 months), 17 patients reached heart transplantation. One patient died and the other is waiting for a transplant. Before transplantation 71% of patients received an appropriate discharge. The mean time to the first appropriate discharge was 2 +/- 2 months (range < 1-6 months), which was significantly shorter than the mean time to first discharge in the other patients (n = 182) receiving a defibrillator in our center (11 +/- 10 months; range 1-58 months) (P < 0.0004). In conclusion, cardiac transplantation candidates with life-threatening ventricular arrhythmias can effectively be protected against sudden arrhythmic death by ICD. These patients have a high incidence of appropriate shocks occurring very early after implantation.

摘要

相似文献

1
Early benefit of implantable cardioverter defibrillator therapy in patients waiting for cardiac transplantation.
Pacing Clin Electrophysiol. 1998 Sep;21(9):1747-50. doi: 10.1111/j.1540-8159.1998.tb00274.x.
2
Implantable cardioverter-defibrillator therapy: influence of left ventricular function on long-term results.植入式心脏复律除颤器治疗:左心室功能对长期疗效的影响。
J Interv Card Electrophysiol. 1997 Nov;1(3):211-20. doi: 10.1023/a:1009716822824.
3
Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders.植入型心律转复除颤器在伴心脏传导障碍的核纤层蛋白 A/C 突变携带者中的应用。
Heart Rhythm. 2013 Oct;10(10):1492-8. doi: 10.1016/j.hrthm.2013.06.020. Epub 2013 Jun 26.
4
Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.多非利特可降低室性心律失常和植入式心脏复律除颤器治疗的频率。
J Cardiovasc Electrophysiol. 2012 Mar;23(3):296-301. doi: 10.1111/j.1540-8167.2011.02183.x. Epub 2011 Sep 28.
5
The implantable cardioverter defibrillator as a "bridge to transplant": a viable clinical strategy?植入式心脏复律除颤器作为“移植桥梁”:一种可行的临床策略?
Am J Cardiol. 1999 Mar 11;83(5B):151D-157D. doi: 10.1016/s0002-9149(98)01017-0.
6
Sudden death in implantable cardioverter-defibrillator recipients: clinical context, arrhythmic events and device responses.植入式心脏复律除颤器接受者的猝死:临床背景、心律失常事件及设备反应
J Am Coll Cardiol. 1999 Jan;33(1):24-32. doi: 10.1016/s0735-1097(98)00519-1.
7
Wearable cardioverter-defibrillator as a bridge to cardiac transplantation: A national database analysis.可穿戴式心脏除颤器作为心脏移植的桥梁:国家数据库分析。
J Heart Lung Transplant. 2015 Oct;34(10):1305-9. doi: 10.1016/j.healun.2015.04.004. Epub 2015 May 4.
8
Implantable cardioverter defibrillator for primary prevention in patients with severe ventricular dysfunction awaiting heart transplantation.用于等待心脏移植的严重心室功能不全患者一级预防的植入式心脏复律除颤器
Transplant Proc. 2013;45(10):3659-61. doi: 10.1016/j.transproceed.2013.10.017.
9
The efficacy of implantable cardioverter-defibrillators in heart transplant recipients: results from a multicenter registry.植入式心脏复律除颤器在心脏移植受者中的疗效:多中心注册研究结果
Circ Heart Fail. 2009 May;2(3):197-201. doi: 10.1161/CIRCHEARTFAILURE.108.814525. Epub 2009 Apr 30.
10
Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study.以胺碘酮为校准剂的塞利伐酮在植入式心脏复律除颤器患者中预防植入式心脏复律除颤器干预或死亡的疗效和安全性:ALPHEE 研究。
Circulation. 2011 Dec 13;124(24):2649-60. doi: 10.1161/CIRCULATIONAHA.111.072561. Epub 2011 Nov 14.

引用本文的文献

1
Association between implantable cardioverter-defibrillator and survival in patients awaiting heart transplantation: A meta-analysis and systematic review.植入式心脏复律除颤器与等待心脏移植患者生存率之间的关联:一项荟萃分析与系统评价
Heart Rhythm O2. 2021 Dec 17;2(6Part B):710-718. doi: 10.1016/j.hroo.2021.09.013. eCollection 2021 Dec.
2
Amiodarone-induced QT prolongation in a newly transplanted heart associated with recurrent ventricular fibrillation.胺碘酮诱发新移植心脏QT间期延长并伴有反复室颤。
Cardiovasc J Afr. 2010 Mar-Apr;21(2):109-12.
3
[Not Available].
[无可用内容]。
Herzschrittmacherther Elektrophysiol. 2000 Jan;11 Suppl 1:79-80. doi: 10.1007/BF03042538.